NCT00531713View on ClinicalTrials.gov

Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

March 31, 2007

Conditions
Quality of LifeDepression
Interventions
DRUG

Triiodothyronine

50 microgram of the usual T4 is withdrawn and the patients is given 20 microgram of T3

Trial Locations (1)

dk-3650

Dept of endocrinology , Herlev Hospital, Herlev

All Listed Sponsors
lead

Copenhagen University Hospital at Herlev

OTHER

NCT00531713 - Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism | Biotech Hunter | Biotech Hunter